|
|
||||||||
Sign In to gain access to subscriptions and/or personal tools. |
|||||||||
ANALGESIA |
From the Section of Dental Pharmacology and Pharmacotherapy (Dr. Bjørnsson, Dr. Skoglund) and the Department of Oral Medicine and Oral Surgery (Dr. Bjørnsson, Dr. Haanæs), University of Oslo, Oslo, Norway.
A randomized, double-blind, within-patient, crossover study was carried out
after bilateral "identical" surgical procedures using local
anesthesia only. A 3-day tablet regime of racemic ketoprofen 75 mg or
acetaminophen 1000 mg qid (x 4) was given starting 3 hours after
surgery. Ketoprofen reduced objectively measured swelling 27.8% (p < 0.04)
better than acetaminophen 3 days after surgery and 70.8% (p < 0.02) better
than acetaminophen 6 days after surgery. The pain intensity (PI) was lower
after ketoprofen than after acetaminophen from 2 to 6 hours after the first
drug intake (all p-values
0.03). Sum PI during the first
(SUMPI3.5-6, p = 0.003) and second dose intervals
(SUMPI6.5-9, p = 0.007) was lower for ketoprofen than for
acetaminophen but not different for the third dose interval
(SUMPI9.5-11, p = 0.53). Ketoprofen was a more effective analgesic
than acetaminophen on the day of surgery (SUMPI3.5-11, p = 0.005).
There was no difference (p > 0.05) between the treatments with respect to
mouth opening, drug preference, global evaluation, or adverse reports. Adverse
reports included stomach pain and diarrhea in both treatment groups.
Ketoprofen 75 mg x 4 for 3 days reduces subjectively assessed pain and
objectively measured swelling (i.e., anti-inflammatory effect) following
third-molar surgery.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
![]() |
P. Bartolucci, T. El Murr, F. Roudot-Thoraval, A. Habibi, A. Santin, B. Renaud, V. Noel, M. Michel, D. Bachir, F. Galacteros, et al. A randomized, controlled clinical trial of ketoprofen for sickle-cell disease vaso-occlusive crises in adults Blood, October 29, 2009; 114(18): 3742 - 3747. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |